Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation
暂无分享,去创建一个
A. Lawson | Terry S Baker | P. Miossec | D. Baeten | P. Vajjah | A. Maroof | Mark I L Watling | N. Yeremenko | S. Shaw | R. Oliver | S. Glatt | F. Strimenopoulou | M. Griffiths | L. Ionescu | S. Popa | T. Baker